Do I have to take Ribociclib for three years?

Ribociclib (Ribociclib) is a targeted or biological therapy. When used to treat breast cancer, reboxiclib is taken with hormone (endocrine) therapy. Riboxiclib is the generic name for this drug, its brand name is Kisqali. It belongs to a group of drugs called CDK (cyclin-dependent kinase) inhibitors. This group of drugs blocks the action of kinases, proteins that help cells grow and divide. By doing this, they stop the cancer from growing and spreading.

When taking Riboxil, patients must drink the entire tablet with water (Do not crush, chew or dissolve). Take the pill at about the same time every day. The official label recommends taking it in the morning. The regular dose is 600 mg. It can be taken with or without food. Specific treatment options should be based on your doctor's recommendations because each patient's situation is different. Normally, the duration of Riboxil treatment will be determined based on the patient's condition and treatment effects. Generally speaking, Riboxil treatment may last for several years, but the specific period of medication needs to be judged by the doctor based on the patient's condition. Only your doctor can determine how long you should use Riboxil based on your specific condition and response to treatment.

The original drug Riboxil has been launched in China, but due to its short time on the market, its price and purchase methods are not yet known, and it has not yet been included in the scope of medical insurance. The price of the European version of Riboxil's original drug, 200mg*21 tablets, sold overseas may be more than RMB 20,000 per box, while the Indian version of Riboxil's original drug, 200mg*21 tablets, may be priced around RMB 3,000 per box (the price may fluctuate due to exchange rates). The ingredients of the two drugs are basically the same. There are currently no generic versions of Riboxil produced and marketed.